- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- August 2022
Global
From €761EUR$790USD£654GBP
- Report
- August 2022
Global
From €761EUR$790USD£654GBP
- Clinical Trials
- February 2020
- 325 Pages
Global
From €2408EUR$2,500USD£2,071GBP
- Report
- September 2022
- 76 Pages
Global
From €3366EUR$3,495USD£2,895GBP
- Report
- May 2023
- 73 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Drug Pipelines
- September 2020
- 35 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Drug Pipelines
- July 2020
- 170 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Report
- November 2023
- 110 Pages
China
From €1733EUR$1,800USD£1,491GBP
- Report
- October 2023
- 91 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Report
- May 2023
- 87 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Report
- August 2021
- 95 Pages
Global
From €3200EUR$3,560USD£2,848GBP
- Report
- February 2024
- 118 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Report
- October 2023
- 93 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Report
- May 2022
- 34 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Drug Pipelines
- March 2021
Global
From €1926EUR$2,000USD£1,656GBP
The Pneumonia Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat bacterial, viral, and fungal pneumonia, as well as other respiratory infections. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Commonly prescribed drugs include antibiotics, antivirals, antifungals, and corticosteroids. In addition, some drugs are used to reduce inflammation and improve breathing.
The Pneumonia Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more